Condensed Balance Sheets - USD ($)		Mar. 31, 2026	Dec. 31, 2025
Current assets
Cash		$ 1,982,569
Prepaid expenses		76,321	25,000
Short-term prepaid insurance		116,125
Total current assets		2,175,015	25,000
Deferred offering costs			491,675
Long-term prepaid insurance		88,967
Cash and marketable securities held in Trust Account		254,987,373
Total Assets		257,251,355	516,675
Current liabilities
Accounts payable and accrued expenses		35,795	40,309
Accrued offering costs		75,000	310,366
Total current liabilities		110,795	516,255
Deferred legal fees		186,374	58,629
Total Liabilities		297,169	574,884
Commitments (Note 6)
Shareholders’ Equity (Deficit)
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding as of March 31, 2026 and December 31, 2025
Additional paid-in capital		364,880	24,157
Retained earnings (accumulated deficit)		1,600,990	(83,209)
Total Shareholders’ Equity (Deficit)		1,966,813	(58,209)
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Equity (Deficit)		257,251,355	516,675
Related Party
Current liabilities
Promissory note - related party			165,580
Class A Ordinary Shares
Current liabilities
Class A ordinary shares subject to possible redemption, 25,300,000 shares and no shares at a redemption value of $10.08 and $0 per share as of March 31, 2026 and December 31, 2025, respectively		254,987,373
Shareholders’ Equity (Deficit)
Ordinary shares, value		100
Class B Ordinary Shares
Shareholders’ Equity (Deficit)
Ordinary shares, value	[1]	$ 843	$ 843

[1] As of December 31, 2025, includes up to 1,100,000 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 5). On January 8, 2026, the underwriters exercised their over-allotment option in full as part of the closing of the Initial Public Offering. As such, the 1,100,000 Founder Shares are no longer subject to forfeiture.